Ai zheng, 2016-12, Vol.35 (12), p.645-646, Article 100
2016
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
- Ist Teil von
- Ai zheng, 2016-12, Vol.35 (12), p.645-646, Article 100
- Ort / Verlag
- London: BioMed Central
- Erscheinungsjahr
- 2016
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- For decades, the selection of chemotherapeutic regimens for the treatment of recurrent or metastatic nasopharyngeal carcinoma has been mainly empirical. To our knowledge, there is no phase 3 trial that has been conducted to determine the optimal treatment for these patients before our publication. Recently, we published an article in The Lancet entitled ＂Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma： a multicentre, randomised, open-label, phase 3 trial.＂ The results of our study indicate that gemcitabine plus cisplatin could improve the survival of patients with recurrent or metastatic nasopharyngeal carcinoma compared with conventional fluorouracil plus cisplatin.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1000-467X, 2523-3548, 1944-446XeISSN: 1944-446X, 2523-3548DOI: 10.1186/s40880-016-0163-6Titel-ID: cdi_doaj_primary_oai_doaj_org_article_c5dcfb8143754842b3a3576152f3a0f3
- Format
- –
- Schlagworte
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Carcinoma, Chemotherapy, Cisplatin - administration & dosage, Deoxycytidine - administration & dosage, Deoxycytidine - analogs & derivatives, Dosage and administration, Drug therapy, Fluorouracil - administration & dosage, Follow-Up Studies, Gemcitabine, Humans, Lymphatic Metastasis, Medical prognosis, Metastasis, Nasopharyngeal cancer, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms - drug therapy, Nasopharyngeal Neoplasms - mortality, Nasopharyngeal Neoplasms - pathology, Nasopharyngeal Neoplasms - secondary, Neoplasm Recurrence, Local - drug therapy, Neoplasm Recurrence, Local - mortality, Neoplasm Recurrence, Local - pathology, Neoplasm Staging, Patient outcomes, Prescription drugs, Prognosis, Research Highlight, Survival Rate